RxDoctor Payments Data

Emily Smith

Women's Health · Wilmington, DENPI 1215456124

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.5% of the total across 93 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 14.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $750 and has fallen 97.4% since, to $20 in 2024.

$1,771in general payments, 2019–2025

Across 93 payments — averaging $19.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mayne Pharma Commercial LLC$261
  • Evofem Biosciences, Inc.$204
  • Astellas Pharma US Inc$202
  • Sage Therapeutics, LLC$127
  • Daiichi Sankyo Inc.$127
  • AbbVie$121
  • plus $729 from 14 others

What the payments were for

  • Food & beverage$1,62192%
  • Education$1508%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,771 in reported general payments places this provider in the 80th percentile of 29 women's health providers in Delaware.

See all women's health providers in Delaware

Most prescribed under Part D

DrugClaimsCost to plans & patients
Estradiol11$687

Paid to pharmacies, not to this prescriber.

Other women's health in Wilmington

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →